1. Market Research
  2. > Therapy
29 reports for Salicylic Acid (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Psoriasis Treatment Market - Analysis By Type, By Treatment Method, By Region, By Country (2020 Edition): Market Insights and Outlook Post Covid-19 Pandemic (2020-2025)

  • $ 1800
  • July 2020
  • 180 pages

salicylic acid, Steroids (corticosteroids), Retinoids, Anthralin, Vitamin D analogue, moisturizer The market of topical treatment is expected to attain the market value of USD ## Million in 2025 from USD ##. ## in 2019 with and emollients which are used to cure mild to moderate psoriasis

  • Autoimmune Disease
  • Pathology
  • Salicylic Acid
  • Therapy
  • AbbVie Inc.

Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)

  • $ 900
  • June 2020
  • 82 pages

The trial showed a statistically significant reduction in the primary composite endpoint of major adverse cardiovascular (CV) events with aspirin plus Brilinta ##mg versus aspirin alone in patients with CAD and type-## diabetes (T##D) at high-risk of a first heart attack or stroke.

  • Autoimmune Disease
  • Salicylic Acid
  • Therapy
  • World
  • AbbVie Inc.

Ulcerative Colitis: Global Drug Forecast and Market Analysis to 2026

  • $ 10995
  • June 2018
  • 272 pages

THESE ANTI-INFLAMMATORY AGENTS INCLUDE ##-AMINO SALICYLIC ACID (##-ASA), CORTICOSTEROIDS, THIOPURINES, CALCINEURIN INHIBITORS, ANTIMETABOLITES, AND BIOLOGICS.

  • Hospital
  • Medical Biotechnology
  • Salicylic Acid
  • Therapy
  • AbbVie Inc.

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • $ 4995
  • March 2018
  • 148 pages

In APAC, it is marketed in Japan, Australia, China, India and South Korea. ##. ##. ## HYDROXYCHLOROQUINE ##. ##. ## LEFLUNOMIDE ##. ##. ## SULFASALAZINE ##. ##. ## CYCLOSPORINE ##. ##. ## XELJANZ (TOFACITINIB) ##. ##. ## OTHER NON-BIOLOGICS ##. ##. ##. ## Non-steroidal Anti-inflammatory Drugs NSAIDs such as aspirin, diclofenac

  • Clinical Trial
  • Monoclonal Antibody
  • Salicylic Acid
  • Therapy
  • AbbVie Inc.

Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market

  • $ 4995
  • June 2018
  • 125 pages

Keratolytics (peeling agents) such as salicylic acid reduce scale from psoriatic plaques.

  • Autoimmune Disease
  • Monoclonal Antibody
  • Salicylic Acid
  • Therapy
  • AbbVie Inc.

Biopharmaceuticals Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 5000
  • August 2019
  • 178 pages

It is also used to treat bleeding caused by certain medications, including salicylates, sulfonamides, quinine, quinidine, or antibiotic.

  • Biopharmaceutical
  • Medical Biotechnology
  • Salicylic Acid
  • United States
  • AbbVie Inc.

The Biopharmaceutical Industry in 2017: Highlights by Therapeutic Area

  • $ 275
  • February 2018
  • 50 pages

The Biopharmaceutical Industry in 2017: Highlights by Therapeutic Area Summary GlobalData’s "The Biopharmaceutical Industry in 2017: Highlights by Therapeutic Area", provides an insight-rich overview ...

  • Therapy
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.

Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • $ 4995
  • April 2017
  • 1 pages

aspirin, diclofenac, ibuprofen and celecoxib are commonly recommended as symptomatic treatments for RA patients.

  • Monoclonal Antibody
  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • AbbVie Inc.

Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth

  • $ 4995
  • June 2017
  • 140 pages

These include NSAIDs such as aspirin, diclofenac, ibuprofen and Celebrex (celecoxib), and analgesics (painkillers), such as codeine.

  • Autoimmune Disease
  • Immunology
  • Salicylic Acid
  • Therapy
  • AbbVie Inc.

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • April 2016
  • 307 pages

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence ...

  • Autoimmune Disease
  • Biosimilar
  • Salicylic Acid
  • Therapy
  • AbbVie Inc.

Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments

  • $ 4995
  • December 2016
  • 133 pages

For example, non-steroidal antiinflammatory drugs, opioids and non-opioid analgesics are used to treat pain that arises in a significant portion of ALS patients, and a number of antidepressants and antipsychotics are used to treat the mental symptoms of the condition.

  • Clinical Trial
  • Dementia
  • Therapy
  • AbbVie Inc.
  • Biogen Idec Inc.

Global Rhematoid Arthritis Drugs Market 2016-2020

  • $ 2500
  • February 2016
  • 126 pages

2016-2020 TECHNAVIO.

  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • AbbVie Inc.
  • Amgen Inc.

Psoriasis - India Drug Forecast and Market Analysis to 2024

  • $ 4995
  • April 2016
  • 208 pages

Psoriasis - India Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. ...

  • Autoimmune Disease
  • Biosimilar
  • Monoclonal Antibody
  • Therapy
  • AbbVie Inc.

Psoriasis - Japan Drug Forecast and Market Analysis to 2024

  • $ 4995
  • April 2016
  • 210 pages

Psoriasis - Japan Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. ...

  • Autoimmune Disease
  • Biosimilar
  • Monoclonal Antibody
  • Therapy
  • AbbVie Inc.

Psoriasis - US Drug Forecast and Market Analysis to 2024

  • $ 4995
  • April 2016
  • 213 pages

Psoriasis - US Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. ...

  • Autoimmune Disease
  • Biosimilar
  • Monoclonal Antibody
  • Therapy
  • AbbVie Inc.

Psoriasis - 5EU Drug Forecast and Market Analysis to 2024

  • $ 6995
  • April 2016
  • 213 pages

Psoriasis - 5EU Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. ...

  • Autoimmune Disease
  • Biosimilar
  • Monoclonal Antibody
  • Therapy
  • AbbVie Inc.

Global Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors

  • $ 4995
  • June 2017
  • 420 pages

Increased use of nonsteroidal anti-inflammatory drugs (including aspirin), hormone-replacement therapy, and statins may have played a role, given their association with reduced colorectal neoplasia (Welch and Robertson, 2016).

  • Monoclonal Antibody
  • Oncology
  • Salicylic Acid
  • Therapy
  • AbbVie Inc.

OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecast to 2025

  • $ 10995
  • November 2016
  • 288 pages

THE PRICE OF NSAIDS WAS DETERMINED FROM THE AVERAGE PRICE OF NAPROXEN, IBUPROFEN, AND ASPIRIN (ASPIRIN, ASPIRINETTA) MADE BY DIFFERENT MANUFACTURERS IN ITALY.

  • Genitourinary System Disease
  • Salicylic Acid
  • Japan
  • United States
  • AbbVie Inc.

Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016 - 2026

  • $ 2349
  • November 2016
  • 240 pages

OVER THE YEARS, THE CHOICE OF THERAPEUTIC INTERVENTIONS FOR THE TREATMENT OF RA HAS GRADUALLY SHIFTED FROM SALICYLATES TO NSAIDS, CORTICOSTEROIDS, SYNTHETIC DMARDS (MTX, SULFASALAZINE, LEFLUNOMIDE AND OTHERS) AND FINALLY TO BIOLOGIC RESPONSE MODIFIERS.

  • Pharmaceutical
  • Salicylic Acid
  • North America
  • United States
  • AbbVie Inc.

Psoriatic Arthritis Market 2015-2019

  • $ 2500
  • December 2015
  • 101 pages

Non-opioid analgesics are commonly used medications because of their efficacy, and these drugs have antipyretic, analgesic, and anti-inflammatory actions.

  • Autoimmune Disease
  • AbbVie Inc.
  • Amgen Inc.
  • Celgene Corporation
  • Janssen Biotech, Inc.
View report >

Monoclonal Antibody Markets in China - Forecast

  • May 2019
  • 18 pages

For example, the molecular mass of Rituximab is about ##, ## Daltons, while aspirin, a well-known small molecule, " weighs" only ## Daltons.

  • Medical Biotechnology
  • Monoclonal Antibody
  • Salicylic Acid
  • China
  • AbbVie Inc.

Therapy Market January 2017

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on